Cassava Sciences
SAVA
#9229
Rank
A$0.14 B
Marketcap
A$3.01
Share price
-1.84%
Change (1 day)
-24.91%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.21 Billion a decrease over its 2023 earnings that were of -A$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion-12.8%
2024 -A$0.21 Billion34.28%
2023 -A$0.15 Billion32.41%
2022 -A$0.12 Billion143.46%
2021 -A$46.39 Million383.92%
2020 -A$9.59 Million36.96%
2019 -A$7 Million-25.56%
2018 -A$9.41 Million-44.25%
2017 -A$16.87 Million-20.11%
2016 -A$21.11 Million5.32%
2015 -A$20.05 Million14.23%
2014 -A$17.55 Million-139.64%
2013 A$44.26 M
2010 -A$19.34 Million102.87%
2009 -A$9.54 Million-177.52%
2008 A$12.29 M-14.32%
2007 A$14.35 M-1942.21%
2006 -A$0.78 Million
2004 -A$54.99 Million75.1%
2003 -A$31.41 Million
2001 -A$24.44 Million20.49%
2000 -A$20.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.21 Billion 31.98%๐Ÿ‡บ๐Ÿ‡ธ USA